These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9373594)

  • 61. Andropause (or symptomatic late-onset hypogonadism): facts, fiction and controversies.
    Morales A
    Aging Male; 2004 Dec; 7(4):297-303. PubMed ID: 15799125
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Patient requests testosterone. When is it actually indicated? (interview by Dr. Ramona Volkert)].
    Schopohl J
    MMW Fortschr Med; 2005 Mar; 147(11):6, 8. PubMed ID: 15803841
    [No Abstract]   [Full Text] [Related]  

  • 63. [Andropause, male climacteric and crisis of the fifties: should androgens be administered?].
    Martin-Du Pan R; Martin-du Pan S; Sindelar P
    Rev Med Suisse Romande; 1995 Mar; 115(3):257-62. PubMed ID: 7777768
    [No Abstract]   [Full Text] [Related]  

  • 64. Compounded Testosterone Troches TO OPTIMIZE HEALTH AND THE TESTOSTERONE CONTROVERSY.
    Guth MA
    Int J Pharm Compd; 2015; 19(3):195-203. PubMed ID: 26714360
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels.
    Cunningham GR
    Endocr Pract; 2013; 19(5):847-52. PubMed ID: 24014001
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Boloña ER; Uraga MV; Haddad RM; Tracz MJ; Sideras K; Kennedy CC; Caples SM; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):20-8. PubMed ID: 17285782
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
    Rhoden EL; Morgentaler A
    J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
    Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
    J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The management of hypogonadism in aging male patients.
    Sharma V; Perros P
    Postgrad Med; 2009 Jan; 121(1):113-21. PubMed ID: 19179819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Andropause (androgen deficiency of the aging male): diagnosis and management.
    Staerman F; Léon P
    Minerva Med; 2012 Oct; 103(5):333-42. PubMed ID: 23042368
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
    Morgunov LIu; Vertkin AL; Pushkar' DIu
    Urologiia; 2007; (5):49-51. PubMed ID: 18254226
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Can testosterone level be a good predictor of late-onset hypogonadism?
    Heidari R; Sajadi H; Pourmand A; Pourmand G
    Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Between physiologic aging and dysfunction. How much testosterone does a man need?].
    Volkert R
    MMW Fortschr Med; 2005 Mar; 147(11):4-5. PubMed ID: 15803840
    [No Abstract]   [Full Text] [Related]  

  • 77. [The testosterone therapy in patients with andropause].
    Krysiak R; Okopień B; Gdula-Dymek A
    Wiad Lek; 2007; 60(7-8):356-64. PubMed ID: 18175556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Testosterone and sexual function.
    Fugh-Berman A; Scialli AR
    Curr Opin Urol; 2017 Nov; 27(6):516-518. PubMed ID: 28795961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Job demands as a potential modifier of the association between testosterone deficiency and andropause symptoms in Japanese middle-aged workers: a cross-sectional study.
    Hirokawa K; Taniguchi T; Fujii Y; Takaki J; Tsutsumi A
    Maturitas; 2012 Nov; 73(3):225-9. PubMed ID: 22871344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risks versus benefits of testosterone therapy in elderly men.
    Basaria S; Dobs AS
    Drugs Aging; 1999 Aug; 15(2):131-42. PubMed ID: 10495072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.